Promoter Reclassification24 Aug 2026, 05:51 pm
Parmax Pharma: Promoter Reclassification Under SEBI LODR Regs
AI Summary
Parmax Pharma Limited has filed an intimation regarding the reclassification of its promoters under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Following an Open Offer and a Share Purchase Agreement, certain individuals and entities will be classified as new promoters and promoter group members, while the erstwhile promoters will be reclassified under the Public Category. This move is in compliance with SEBI regulations, with undertakings provided by the parties involved confirming adherence to the stipulated conditions for reclassification.
Key Highlights
- Promoter reclassification initiated as per SEBI LODR Regulations 31A.
- New promoters and promoter group members identified post Open Offer.
- Erstwhile promoters to be reclassified into the Public Category.
- Transaction involves acquisition of 30.80% equity shares.
- Compliance with SEBI's conditions for reclassification confirmed.
Price Impact
More from PARMAX